|
NEK9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.96159999999691E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.987500E-04 |
| Normal-vs-Stage2 |
1.96256999999145E-05 |
| Normal-vs-Stage3 |
2.33140000005516E-06 |
| Normal-vs-Stage4 |
4.055000E-01 |
| Stage1-vs-Stage2 |
3.893800E-02 |
| Stage1-vs-Stage3 |
2.624000E-02 |
| Stage1-vs-Stage4 |
9.967400E-01 |
| Stage2-vs-Stage3 |
9.463600E-01 |
| Stage2-vs-Stage4 |
5.403400E-01 |
| Stage3-vs-Stage4 |
5.534800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.177520E-04 |
| Normal-vs-AfricanAmerican |
3.546100E-02 |
| Normal-vs-Asian |
5.157400E-01 |
| Caucasian-vs-AfricanAmerican |
3.685400E-01 |
| Caucasian-vs-Asian |
5.427900E-02 |
| AfricanAmerican-vs-Asian |
1.676960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.619900E-04 |
| Normal-vs-Female |
7.013000E-04 |
| Male-vs-Female |
4.483600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.260500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.342810E-01 |
| Normal-vs-Age(61-80Yrs) |
2.76539999788383E-08 |
| Normal-vs-Age(81-100Yrs) |
3.84610000000452E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.992400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.158800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.519000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.062000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.042100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.758000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.727700E-02 |
| Normal-vs-Grade 2 |
9.233100E-04 |
| Normal-vs-Grade 3 |
1.16439999864326E-08 |
| Normal-vs-Grade 4 |
4.152400E-01 |
| Grade 1-vs-Grade 2 |
3.363500E-04 |
| Grade 1-vs-Grade 3 |
3.02490000003708E-06 |
| Grade 1-vs-Grade 4 |
1.369630E-01 |
| Grade 2-vs-Grade 3 |
1.357330E-03 |
| Grade 2-vs-Grade 4 |
9.271200E-01 |
| Grade 3-vs-Grade 4 |
6.018800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.675750E-03 |
| Normal-vs-ccB subtype |
1.98780000004728E-06 |
| ccA subtype-vs-ccB subtype |
3.432100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.599900E-02 |
| Normal-vs-N1 |
3.00149999998833E-06 |
| N0-vs-N1 |
1.779690E-02 |
|
|
